Fig. 1From: Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysisStudy flowchart to illustrate the study selection and follow-up. T2D, type 2 diabetes; ACS, acute coronary syndromeBack to article page